Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance

Autor: Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet, Katell Le Lay

Publikováno v: Journal of Market Access & Health Policy, Vol 12, Iss 2, Pp 105-117 (2024)

Background: Real-world evidence (RWE) can reinforce clinical trial evidence in health technology assessment (HTA). Objectives: Review HTA bodies’ (HTAbs) requirements for RWE, real uses, and acceptance across seven countries (Brazil, Canada, France

Externí odkaz: https://doaj.org/article/402fac064ee64a2797cde8a8b2c31ab4

Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease

Autor: Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay, Marine Sivignon, Claire Leboucher, Cécile Blein, François Raffi

Publikováno v: Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)

Background Quantification of COVID-19 burden may be useful to support the future allocation of resources.Objective To evaluate the public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.Study d

Externí odkaz: https://doaj.org/article/127e431a65e14202bacc9742e0797ce4

Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study.

Autor: Vincent Cottin, Aurélie Schmidt, Laura Catella, Fanny Porte, Céline Fernandez-Montoya, Katell Le Lay, Stève Bénard

Publikováno v: PLoS ONE, Vol 12, Iss 1, p e0166462 (2017)

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with an unpredictable course. An observational study was set up using the French hospital discharge database to describe the reasons, outcomes and costs of hospitalisations related to this d

Externí odkaz: https://doaj.org/article/3ccdafeb68e34a808d2833a8732b29ce

Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)

Autor: Sophie Larrieu, Jacques Massol, Loic Boussel, Françoise Thivolet-Béjui, Katell Le Lay, Mouhamad Nasser, Lara Chalabreysse, Fabienne Bazin, Salim Si-Mohamed, Vincent Cottin, Delphine Maucort-Boulch, Sébastien Marque, Eric Hachulla, Stéphane Jouneau

Publikováno v: Respiratory Research
Respiratory Research, BioMed Central, 2021, 22 (1), pp.162. ⟨10.1186/s12931-021-01749-1⟩
Respiratory Research, 2021, 22 (1), pp.162. ⟨10.1186/s12931-021-01749-1⟩
Respiratory Research, Vol 22, Iss 1, Pp 1-15 (2021)

Background There is a paucity of data on the epidemiology, survival estimates and healthcare resource utilisation and associated costs of patients with progressive fibrosing interstitial lung disease (PF-ILD) in France. An algorithm for extracting cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf52a1dfef769002071ffe002e11cb89
https://hal.archives-ouvertes.fr/hal-03260533

Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in

Autor: Nicolas, Girard, Denis, Moro-Sibilot, Stéphane, Bouée, Corinne, Emery, Elodie, Torreton, Katell, Le Lay, Laura, Luciani, Christophe, Maritaz, Christos, Chouaid

Publikováno v: Future oncology (London, England). 16(16)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b268b43be9a2409e855b0efbb35ed5b
https://pubmed.ncbi.nlm.nih.gov/32352321